Author:
Lee Ji-Hyun,Poudel Barun,Ki Hyeon-Hui,Nepali Sarmila,Lee Young-Mi,Shin Jeon-Soo,Kim Dae-Ki
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Alves, R. C. et al. Advanced hepatocellular carcinoma. Review of targeted molecular drugs. Annals of hepatology. 10, 21–27 (2011).
2. Waly, R. S., Yangde, Z. & Yuxiang, C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncology. 2012, 421673,
https://doi.org/10.5402/2012/421673
(2012).
3. Giannini, E. G. et al. Prognosis of untreated hepatocellular carcinoma. Hepatology. 61, 184–190 (2015).
4. Tang, H., Li, R. P., Liang, P., Zhou, Y. L. & Wang, G. W. miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncology letters. 10, 681–686 (2015).
5. Roba, M. T. et al. Serum Levels of Complement C1Q, C3 and C4 in Patients at Different Stages of Chronic Hepatitis C ViralInfection. World Journal of Medical. 2, 88–95 (2007).
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献